Mepolizumab for treating severe eosinophilic asthma
Technology appraisal guidance
Reference number: TA671
Published:
Topic update: this appraisal was due to pause at ERG report delivery, however the topic will now continue on the original timelines and no longer pause at this point. The timelines have been updated on this webpage.